文献速递鼻科

内镜下改良Lothrop手术的演变:系统综述与荟萃分析

Evolution of the endoscopic modified Lothrop procedure: A systematic review and meta-analysis.
PubMed 文献 · Laryngoscope · 2017-09-16

该系统综述与荟萃分析纳入29篇文章共1205例患者,比较早期(1990-2008)与当代(2009-2016)内镜下改良Lothrop手术(EMLP)的适应证和结局,并比较随访≥2年与<2年的差异。结果显示总体症状改善率86.5%,通畅率90.7%,再手术率12.6%;当代组肿瘤适应证更多、症状改善率更高,长期随访组再手术率更高。

要点

  • EMLP总体症状显著或完全改善率86.5%,总体通畅率90.7%,再手术率12.6%。
  • 当代组(2009-2016)较早期组更常用于肿瘤,症状改善率更高(90.0% vs 82.6%)。
  • 随访超过2年再手术率显著高于短期随访(14.5% vs 9.2%)。

核心结论

  • 近十年EMLP更多用于肿瘤,近期研究显示症状结局改善且通畅率有改善趋势。
  • 随访超过2年时再手术率显著增加。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、SCOPUS和Cochrane数据库的英文文献(1990-2016)。
  • 共纳入29篇文章,提取1205例患者,平均随访29.1±10.3个月。
  • 使用Statistical Analysis System 9.4进行荟萃分析。

主要发现

  • 总体症状显著或完全改善率为86.5%(95%CI:84.2%-88.7%)。
  • 总体通畅率为90.7%(95%CI:89.1%-92.3%),再手术率为12.6%(95%CI:10.6%-14.3%)。
  • 当代组较早期组更常用于肿瘤(P < .001),症状显著或完全改善率更高(90.0% vs 82.6%,P < .001)。
  • 当代组较早期组通畅率有更高趋势(92.1% vs 88.6%,P = .052)。
  • 长期随访组较短随访组症状改善和通畅率无差异,但再手术率更高(14.5% vs 9.2%,P = .016)。

临床怎么用

  • EMLP可用于肿瘤适应证,当代研究显示症状改善率提高。
  • 随访超过2年时应警惕再手术风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Since first described in the 1990s, the endoscopic modified Lothrop procedure (EMLP) has been the subject of a growing body of literature. We performed a review to compare indications and outcomes of EMLP in an early cohort of publications (1990-2008) versus a contemporary cohort (2009-2016) and compare outcomes associated with follow-up ≥2 years versus <2 years. DATA SOURCES: PubMed, SCOPUS and Cochrane databases. REVIEW METHODS: An English-language search of the PubMed and Ovid databases was conducted to identify publications from 1990 to 2016 reporting clinical outcomes of EMLP. Meta-analysis was performed using Statistical Analysis System 9.4. RESULTS: A total of 1,205 patients were abstracted from 29 articles with a mean follow-up of 29.1 ± 10.3 months. The overall rate of significant or complete symptom improvement was 86.5% (95% confidence interval [CI]: 84.2%-88.7%). The overall patency rate was 90.7% (95% CI: 89.1%-92.3%), with a revision rate of 12.6% (95% CI: 10.6%-14.3%). Compared to the early cohort, patients in the contemporary cohort underwent EMLP more often for tumors (P < .001), had higher rates of complete or significant symptom improvement (90.0% vs. 82.6 %, P < .001); and trended toward greater patency rates (92.1% vs. 88.6%, P = .052). Compared to the short-term follow-up cohort, the long-term cohort showed no differences in symptom improvement or patency, but the revision rate was higher (14.5% vs. 9.2%, P = .016). CONCLUSIONS: In the last decade, EMLP has been performed more frequently for tumors. Recent studies have demonstrated improved symptom outcomes and a trend toward improved patency rates. The revision rate increased significantly when follow-up exceeded 2 years. Laryngoscope, 128:317-326, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Shih LC, Patel VS, Choby GW, et al. Evolution of the endoscopic modified Lothrop procedure: A systematic review and meta-analysis. Laryngoscope. 2017. PMID: 28921539. doi:10.1002/lary.26794

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。